Année d’arrivée au Centre
2018
Parcours professionnel
- Praticien spécialiste des CLCC, Institut Curie, Paris
- Praticien assistant spécialiste des CLCC, Institut Curie, Paris
- Research Fellow (Molecular Pathology), Memorial Sloan-Kettering Cancer Center, NY, USA
- Surgical Pathology Fellow, Mayo clinic, MN, USA Internat de Hôpitaux de Paris, Paris VI
Formation
- DU Diagnostic et prise en charge des sarcomes. Paris Descartes
- Diplôme d’Etudes Spécialisées en Anatomie et Cytologie Pathologiques, Paris VI
- Doctorat en médecine, Paris VI
- Master 2 cancérologie, Paris XI
Interventions pratiquées ou expertise
- Expertise en pathologie mammaire, gynécologique, ORL, sarcomes, pathologie moléculaire
- Membre du réseau de relecture RRePS, NETSARC+
- Membre du réseau de relecture RRePS gynécologie
- Membre du réseau de relecture REFCORpath
Sociétés savantes
- Membre de l’Académie internationale de Pathologie
- Membre de la Société Française de Pathologie
- Membre du Copath Membre du Groupe Sarcome Français
Publications majeures
- Pan-TRK immunohistochemistry is highly correlated with NTRK3 gene rearrangements in salivary gland tumors . Am J Surg Pathol 2021.
- Lower Rate of CTNNB1 Mutations and Higher Rate of APC Mutations in Desmoid Fibromatosis of the Breast: A Series of 134 Tumors. Am J Surg Pathol. 2020 Sep;44(9):1266-1273.
- Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer. J Natl Cancer Inst. 2020 Feb 1;113(2):146-153
- Interaction Between Molecular Subtypes and Stromal Immune Infiltration Before and After Treatment in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. Clin Cancer Res. 2019 Nov 15;25(22):6731-6741.
- Nuclei Segmentation of nuclei in Histopathology images by deep regression of the distance map. IEEE Trans Med Imaging. 2019 Feb;38(2):448-459.
- Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database. Ann Oncol. 2017 Aug 1;28(8):1979-1987.
- Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer. Ann Oncol. 2017 Sep 1;28(9):2233-2240.
- Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study. Lancet Oncol. 2016 2016 Apr;17(4):532-8.
- Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol. 2010 May 1;28(13):2151-8.
- Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients. Ann Oncol. 2010 Apr;21(4):815-9.